ZeClinics has achieved outstanding success in maximizing visibility in the US market through its participation in the EIC Overseas Trade Fair (OTF) 2.0 Program, especially at BIO 2022 and 2023. Selected to exhibit at the prestigious European Pavilion of the BIO International Convention, ZeClinics developed significant connections with industry leaders. Daniel Caballero Díaz, the Sales & Account Manager at ZeClinics, shared insights on positive experiences gained during international trade fairs.
Read the full interview with Daniel Caballero Díaz and connect with ZeClinics to learn more about our innovative preclinical services using zebrafish and our mission to accelerate drug and target discovery.
Looking ahead, ZeClinics aims to improve and expand its services, adding more value to existing clients and making them beneficial to a broader audience. The company is committed to challenging the discovery process by combining expertise in zebrafish biology with laboratory automation and artificial intelligence.